Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Assets Average (2023 - 2025)

Mangoceuticals' Assets Average history spans 3 years, with the latest figure at $18.7 million for Q3 2025.

  • For Q3 2025, Assets Average rose 24.46% year-over-year to $18.7 million; the TTM value through Sep 2025 reached $18.7 million, up 24.46%, while the annual FY2024 figure was $8.2 million, N/A changed from the prior year.
  • Assets Average for Q3 2025 was $18.7 million at Mangoceuticals, down from $21.3 million in the prior quarter.
  • Across five years, Assets Average topped out at $21.3 million in Q2 2025 and bottomed at $676120.0 in Q1 2024.
  • The 3-year median for Assets Average is $11.4 million (2024), against an average of $10.5 million.
  • The largest YoY upside for Assets Average was 2645.4% in 2025 against a maximum downside of 24.46% in 2025.
  • A 3-year view of Assets Average shows it stood at $1.3 million in 2023, then skyrocketed by 1039.8% to $15.1 million in 2024, then rose by 23.91% to $18.7 million in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Assets Average are $18.7 million (Q3 2025), $21.3 million (Q2 2025), and $18.6 million (Q1 2025).